Identification |
Name: | PHYSOSTIGMINE SALICYLATE (1:1) |
Synonyms: | Eserinesalicylatesalt;Physostigminesalicylate |
CAS: | 57-64-7 |
EINECS: | 200-343-8 |
Molecular Formula: | C15H21N3O2•C7H6O3 |
Molecular Weight: | 275.34614 |
InChI: | InChI=1S/C15H21N3O2/c1-15-7-8-17(3)13(15)18(4)12-6-5-10(9-11(12)15)20-14(19)16-2/h5-6,9,13H,7-8H2,1-4H3,(H,16,19)/t13-,15+/m1/s1 |
Molecular Structure: |
|
Properties |
Transport: | UN 1544 6 |
Density: | g/cm3 |
Water Solubility: | Sparingly soluble in water; soluble in ethanol (~750 g/l) TS; slightly soluble in ether R. |
Solubility: | Sparingly soluble in water; soluble in ethanol (~750 g/l) TS; slightly soluble in ether R. |
Appearance: | Colourless crystals; odourless. |
Specification: |
1.General Description: Crystal form that turns red on exposure to heat or light.
2.Reactivity Profile: Behaves as a weak acid in solution.
3.Health Hazard : Physostigmine salicylate (1:1) (CAS NO.57-64-7) is similar to physostigmine. It is classified as super toxic. The probable oral lethal dose (humans) is less than 5 mg/kg or a taste for a 150 lb. person. It is a cholinesterase inhibitor.
4.Fire Hazard: When heated to decomposition, Physostigmine salicylate (1:1) (CAS NO.57-64-7) emits toxic fumes of nitrogen oxides.
|
Report: |
EPA Extremely Hazardous Substances List. Reported in EPA TSCA Inventory.
|
Packinggroup: | II |
Color: | ORTHORHOMBIC SPHENOIDAL PRISMS OR CLUSTERS OF LEAFLETS FROM ETHER OR BENZENE WHITE MICROCRYSTALLINE POWDER Colorless or pinkish crystals |
Usage: | Physostigmine salicylate (Eserine salicylate) is used as bulk pharmaceuticals (parasympathomimetic, cholinergic, ophthalmic, anti-Alzheimer). Product Data Sheet |
Safety Data |
Hazard Symbols |
T+: Very toxic
|
|
|